Published on Web 03/23/2002
Asymmetric Synthesis of A-240610.0 via a New Atropselective
Approach for Axially Chiral Biaryls with Chirality Transfer
Yi-Yin Ku,* Tim Grieme, Prasad Raje, Padam Sharma, Steve A. King, and
Howard E. Morton
Contribution from D-R450, Process Chemistry, Global Pharmaceutical Research and
DeVelopment, Abbott Laboratories, North Chicago, Illinois 60064-4000
Received September 19, 2001
Abstract: A new approach for atropselective preparation of axially chiral biaryl was developed. This process
proceeded through a chirality transfer from a stereogenic center of a secondary alcohol to the stereogenic
axis via regioselective intramolecular silyl group migration. This methodology allowed for the preparation
of a single atropisomer 2 in good yield (85%) with high diastereoselectivity (99:1), which subsequently led
to the successful development of an efficient asymmetric synthesis of A-240610.0, 1.
Introduction
of two or more stable (noninterconverting) rotational isomers,
has played an important role in asymmetric synthesis.6 The
Glucocorticoids have been used for the treatment of inflam-
matory diseases for the last 40 years,1 but many undesirable
side effects2 are associated with the current therapies. These
side effects largely occur because glucocorticoids have poor
selectivity toward the glucocorticoid receptor3 and have cross-
reactivity with other steroid receptors.4 A-240610.05 has dem-
onstrated equivalent antiinflammatory activity relative to that
of the synthetic glucocorticoids, such as prednisolone,1c and has
shown an improved side effect profile in vivo.
increasing awareness of the importance of axial chirality in
organic chemistry is partially due to the growing number of
isolated chiral biaryl natural products.7 Currently, considerable
efforts are directed toward effective generation and control of
axial chirality for the synthesis of axially chiral biaryls.8 Besides
the commonly used methodology of resolution of a racemic
mixture, several regio- and stereoselective approaches have been
recently developed.9
We were not able to achieve an efficient synthesis of
A-240610.0 using the existing methodologies. For example,
(6) (a) Noyori, R. Asymmetric Catalysis in Organic Synthesis; Wiley: New
York, 1994; (b) Rosini, C.; Franzini, L.; Raffaelli, A.; Salvadori, P. Synthesis
1992, 503. (c) Kagan, H. B.; Riant, O. Chem. ReV. 1992, 92, 1007. (d)
Narasaka, K. Synthesis 1991, 1. (e) Bao, J.; Wulff, W. D.; Rheingold, A.
L. J. Am. Chem. Soc. 1993, 115, 3814 and references therein.
(7) (a) Meyers, A. I.; Willemsen, J. J. Tetrahedron 1998, 54, 10493. (b) Torssell,
K. B. G. Natural Product Chemistry; Taylor and Fancis: New York, 1997.
(c) Bringmann, G.; Pokorny, F. In The Alkaloids; Cordell, G. A., Ed.:
Academic: New York, 1995; Vol. 46, p 127. (d) Okuda, T.; Yoshida, T.;
Hatano, T. In Progress in the Chemistry of Organic Natural Products; Herz,
W., Kirby, G. W., Moore, R. E., Steglich, W., Tamm, C., Eds.; Springer:
Wien, 1995; Vol. 66, p1.
During the process of developing an asymmetric synthesis
for A-240610.0, we needed to prepare the homoallylic alcohol
2 as a single atropisomer to effect an efficient ether-forming
reaction (vide infra). Axial chirality, resulting from the formation
(8) (a) Review: Bringmann, G.; Breuning, M.; Tasler, S. Synthesis 1999, 4,
525. (b) Review: Bringmann, G.; Walter, R.; Weirich, R. Angew. Chem.,
Int. Ed. Engl. 1990, 29, 977. (c) Review: Bringmann, G.; Walter, R.;
Weirich, R. Methods of Organic Chemistry (Houben-Weyl); Helmchen, G.,
Hoffmann, R. W., Mulzer, J., Schumann, E., Eds.; Georg Thieme Verlag:
Stuttgart, 1995; Vol. E21a, p 567. (d) Hattori, T.; Hotta, H.; Suzuki, T.;
Miyano, S. J. Chem. Soc., Chem. Commun. 1991, 1375. (e) Hattori, T.;
Hotta, H.; Suzuki, T.; Miyano, S. Bull. Chem. Soc. Jpn. 1993, 66, 613. (f)
Miyano, S.; Koike, N.; Hattori, T. Tetrahedron: Asymmetry 1994, 5, 1899.
(g) Moorlag, H.; Meyers, A. I. Tetrahedron Lett. 1993, 34, 6989. (h)
Moorlag, H.; Meyers, A. I. Tetrahedron Lett. 1993, 34, 6993. (i) Nelson,
T. D.; Meyers, A. I. J. Org. Chem. 1994, 59, 2655. (j) Nelson, T. D.;
Meyers, A. I. Tetrahedron Lett. 1994, 35, 3259. (k) Meyers, A. I.;
McKennon, M. J. Tetrahedron Lett. 1995, 36, 5869. (l) Meyers, A. I.; Meir,
A.; Rawson, D. J. Tetrahedron Lett. 1992, 33, 853. (m) Shindo, M.; Koga,
K.; Tomioka, K. J. Am. Chem. Soc. 1992, 114, 8732. (n) Uemura, M.;
Kamikawa, K. J. Chem. Soc., Chem. Commun. 1994, 2697. (o) Kamikawa,
K.; Watanabe, T.; Uemura, M. Synlett 1995, 1040. (p) Watanabe, T.;
Kamikawa, K.; Uemura, M. Tetrahedron Lett. 1995, 37, 6695. (q)
Kamikawa, K.; Watanabe, T.; Uemura, M. J. Org. Chem. 1996, 61, 1375.
(r) Osa, T.; Kashiwagi, Y.; Yanagisawa, Y.; Bobbitt, J. M. J. Chem. Soc.,
Chem. Commun. 1994, 2535. (s) Itoh, T.; Chika, J.; Shirakami, S.; Ito, H.;
Yoshida, T.; Kubo, Y.; Uenishi, J. J. Org. Chem. 1996, 61, 3700. (t)
Nakajima, M.; Miyoshi, I.; Kanayama, K.; Hashimoto, S.; Noji, M.; Koga,
K. J. Org. Chem. 1999, 64, 2264.
* To whom correspondence should be addressed. E-mail: yiyin.ku@
abbott.com.
(1) (a) Schimmer, B. P.; Parker, K. L. In Goodman and Gilman’s The
Pharmacological Basis of Therapeutics, 9th ed.; Hardman, J. G., Limbird,
L. E., Molinoff, P. B., Ruddon, R. W., Eds.; McGraw-Hill: New York,
1996; pp 1459. (b) Cohen, E. M. Anal. Profiles Drug Subst. 1973, 2, 163.
(c) Ali, S. L. Prednisolone. Anal. Profiles Drug Subst. Excipients 1992,
21, 415.
(2) (a). Gennari, C. Br. J. Rheumatol. 1993, 32, 11. (b) Anon. Effects of
Dexamethasone on Glucose Metabolism. Nutr. ReV. 1976, 34, 185-187.
(3) Weinberger, C.; Hollenberg, S. M.; Ong, E. S.; Harmon, J. M.; Brower, S.
T.; Cidlowski, J.; Thompson, E. B.; Rosenfeld, M. G.; Evans, R. M. Science
1985, 228, 740-742.
(4) (a) Mulatero, P.; Veglio, F.; Pilon, C.; Rabbia, F.; Zocchi, C.; Limone, P.;
Boscaro, M.; Sonino, N.; Fallo, F. J. Clin. Endocrinol. Metab. 1998, 83,
2573. (b) Neef, G.; Beier, S.; Elger, W.; Henderson, D.; Wiechert, R.
Steroids 1984, 44, 349-372.
(5) Coughlan, M. J.; Elmore, S. W.; Kort, M. E.; Kym, P. R.; Moore, J. L.;
Pratt, J. K.; Wang, A. X.; Edwards, J. P.; Jones, T. K. Glucocorticoid-
Selective Antiinflammatory Agents. Patent (PCT), WO99/41256, 1999.
9
4282
J. AM. CHEM. SOC. 2002, 124, 4282-4286
10.1021/ja0171198 CCC: $22.00 © 2002 American Chemical Society